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COVID-19 pandemic has taught the world researchers the urgent need for new sources and novel 
pharmaceuticals not only for existing diseases but also for both seasonal epidemics and future 
pandemics. Pharmaceutical drug discoveries for the past fifty years depended deeply on the procedure of 
empirical transmission of a huge number of pure bioactive compounds to provide new leads. The 
screening of extracts or isolating compounds is a common way to discover novel biologically active 
molecules. Most of the valuable Blue-Green algal metabolites are concentrated in their biomass. For 
existence in nature, Blue-Green algae (BGA) secrete and contain various organic substances like 
proteins, fatty acids, vitamins, pigments, primary and secondary metabolites, and these compounds are 
explored for potential biological activities such as antibacterial, antifungal, antiviral (including the anti-
SARS-CoV-2 virus that causes COVID-19), anticancer, antioxidant, antidiabetic, protease inhibitory 
activity, anti-inflammatory activity, etc. Due to their diverse application, pharmaceutical companies 
have shown commercial interest in the Blue-green algal group for the discovery and development of 
novel molecules to combat deadly diseases for the benefit of society and mankind. The current review 
paper highlights and discusses the diverse pharmaceutical potential of laboratory-grown cultures of 
BGA along with comprehensive and current knowledge on bioactive compounds discovered by 
researchers globally. 
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1 Introduction  
In the extremely competitive environment of current 
pharmaceutical research and development of new molecules, 
natural products offer a unique element of molecular diversity and 
biological functionality, which is essential for drug discovery 
(Bernardini et al., 2018; Chatterjee et al., 2019; Atanasov et al., 
2021). The study of secondary metabolites that organisms such as 
microbes including BGA and plants have evolved, largely for their 
survival, has historically proved of immense benefit in drug 
discovery and development (Petersen et al., 2020). They are 
providing a rich source of structurally novel bioactive molecules 
such as lipopeptides, amino acids, fatty acids, etc., many of which 
have become life-saving drugs (Singh et al., 2021a). In recent 
decades, pharmaceutical inventions are focused on natural sources 
(microbial sources such as bacterial, fungi, algal including Blue-
green algae) which can deal with recent diseases. Medicinal 
chemistry is the backbone of lead generation in early drug 
invention where small molecule hits from high throughput screen 
(HTS), which leads to limited optimization and identification of 
lead compounds (Jimenez-Lopez et al., 2021). Despite these 
efforts, some new chemical entities have reached the market, and 
researchers throughout the world now are giving more attention to 
exploring these groups of microorganisms (including microbes 
from extreme environments i.e., Arctic, Antarctic) for extractions 
of novel compounds with diverse pharmaceutical applications. 
1.1 The need for novel Pharmaceutically important compounds  
The less accessibility and high cost of new generation antibiotics 
necessitate looking for the substances from alternative medicines 
with claimed antimicrobial activity. Today, most of the diseases 
caused by pathogens can be cured with the help of available 
antibiotics, but the discovery of any new antibiotic generally 
follows up with a course of resistance mechanism building up 
against it among the target organisms (Dimri et al., 2018). This 
phenomenon is known as ‘antibiotic resistance is developing 
among microbial species at an appreciable rate, is a formidable 
complication of prudent and overuse of available antibiotics, and is 
imposing a serious health threat to human welfare. World Health 
Organization (WHO) in February 2017 published a report of 
antimicrobial-resistant bacteria for which new pharmaceutical 
compounds are urgently needed (WHO, 2017). Keeping in view 
the urgent requirement, the current review highlights various 
important aspects about the pharmaceutical potential of laboratory-
grown cultures of BGA. 
1.2 Blue-Green Algae 
Blue-green algae are a group of extraordinary, diverse, gram-
negative, oxygenic, photosynthetic prokaryotic, microscopic oldest 
organisms that originated 3.5 billion years ago (Kaushik et al., 
2009). Blue-green algae are found all over the world, shows 
remarkable ecological diversity of habitats such as Freshwater 
(Khatoon et al., 2018; Chittapun et al., 2020), Terrestrial (Radzi et 
al., 2019; Riba et al., 2020), Marine (Basu et al., 2019; Uma et al., 
2020), Hot spring (Tang et al., 2018; Cheng et al., 2020), etc. 
These BGA are also widely distributed in the polar region such as 
the Arctic, Antarctic, Southern Ocean, and Himalayas (Singh & 
Elster, 2007; Rego et al., 2019; Zaki et al., 2020). It has been 
estimated that about 2000 strains of freshwater and marine BGA 
are distributed all over the world. The capability to grow in adverse 
conditions and their autotrophic nature makes them an eligible 
candidate to grow in low nutrient-deficient lakes, ponds, and 
oceans which pose a serious threat to water and result in 
eutrophication. This may cause unpleasant tastes and odors of 
water through the secretion of volatile compounds. Random 
screening of blue-green algae will continue to play an important 
role in the drug discovery process for the foreseeable future. 
Several studies have been conducted for the isolation and 
identification of Blue-Green Algae from water, soil, sediments, algal 
mats, etc. (Figure 1-8) using advanced morphological, physiological, 
and molecular characterization techniques (Bellinger & Sigee, 2015; 
Hokmollahi et al., 2016; Radkova et al., 2020). These BGA have 
successfully grown on a laboratory scale using selective media i.e. 
BG-11, BG-13, Chu 10 (Chu, 1942; Rippka et al., 1979; Kaushik et 
al., 2010), Allen and Arnon Medium (Allen & Arnon, 1955), Fogg’s 
Medium (Fogg’s. 1965), Modified Bristol’s Medium (Bold, 1949) 
and Pringsheim’s Medium (Pringsheim, 1946). Blue-green algae do 
not require carbon or energy sources in their growth medium. Thus, 
they require only a basic inorganic medium, which has several 
logical advantages when performing the mass culture and 
purification of active compounds. Flask cultivation and mass 
cultivation for instance open pond system, hybrid system, closed 
photobioreactors are very well-known culturing methods used for 
generating biomass maintaining proper light, temperature, water, 
CO2 supply, pH, nutrient supply, and proper mixing (Kaiwan-arporn 
et al., 2012; Troschl et al., 2017; Al-Saman et al., 2020; Jo et al., 
2020). Lyophilization (freeze-drying), air drying, and sun-drying are 
some known popular techniques to convert biomass into powder 
(Smetana et al., 2017). Aqueous extraction i.e. cold and hot water 
extraction, organic extraction i.e. polar solvent extraction, semi-polar 
solvent extraction, non-polar solvent extraction, mix solvents 
extraction and sequential extractions, soxhlet extraction have been 
used extensively to isolate medicinal value active ingredients 
(Fatima et al., 2017; Vanlalveni et al., 2018; Yücer et al., 2018; 
Saurav et al., 2019). Generally, all blue-green algae vegetative cells 
contain carboxysomes, pseudocrystalline aggregates of the key 
enzymes of CO2 fixation via the reductive pentose phosphate 
pathway and glycogen is a general carbohydrate reserve material of 
cyanobacteria. Other cellular inclusions include Poly-β-
hydroxybutyrate (PHB) granules, cyanophycean granules, 
polyphosphate granules, carboxysomes or polyhedral bodies, and gas  
 
 









vesicles (Stanier, 1988). They show notable ecological diversity. 
Because of extensive eutrophication of lakes, ponds and some parts 
of oceans BGA often forms blooms, which lead to water hygienic 
problems (Chorus et al., 2000; Duy et al., 2000). They may cause 
unpleasant tastes and odors through the excretion of volatile 
compounds (Jones & Korth, 1995; Liu et al., 2006). 
 
Figure 1 Laboratory Grown Culture of BGA (Medium: BG-11): A. Calothrix sp., B. Spirulina sp. C. Oscillatoria sp. 
 
   
Figure 2 Microscopic images of Anabaena species (Chauhan & Jindal, 2020) 
 
   
Figure 3 Microscopic images of Nostoc species (Chauhan & Jindal, 2020) 
 
   





















    
Figure 5 Microscopic images of Oscillatoria species (Chauhan & Jindal, 2020) 
 
    
Figure 6 Microscopic images of spirulina species (Chauhan & Jindal, 2020) 
 
    
Figure 7 Scanning Electron Micrograph (SEM) image of Anabaena sp. (A) and Nostoc sp. (B) as per Kaushik & Chauhan (2008a) 
 
 















2 Pharmaceutical Potential of BGA 
Blue-green algae are the rich source of structurally novel and 
biologically active metabolites with diverse antibacterial, 
antifungal, antiviral (including the anti-SARS-CoV-2 virus that 
causes COVID-19), anticancer, antioxidant, antidiabetic, protease 
inhibitory activity, anti-inflammatory activity, immunomodulatory 
activity, larvicide, and protease inhibitory activity, etc. (Figure 9) 
(Nainangu et al., 2020; Jafari et al., 2021). The first time before 
1500 BC, medicinal and nutritional properties have been 
investigated for Nostoc algal species to treat gout, fistula, and 
cancer (Cardellina et al., 1979a; Shishido et al., 2020).  
These photosynthetic microorganisms can yield proteins, 
carbohydrates, and lipids as a result of photosynthesis thus referred 
to as important biological resources having a wide range of 
biotechnological applications in the modern world due to their 
ability to grow rapidly even in harsh environmental conditions 
(Padmini et al., 2021). A search of these organisms for medicinal 
purposes has revealed important chemical prototypes for the 
finding of new agents, stimulating the use of refined physical 
techniques and new syntheses of molecules with the 
pharmaceutical application for human welfare. Phytochemical’s 
constituents described from extracts of Blue-Green algae have 
been described by researchers (Figure 10) and are very well 
documented (Vasudevan et al., 2020; Nainangu et al., 2020; Gabr 
et al., 2020; Vasudevan et al., 2020) 
2.1 Pharmaceutically important compounds isolated from BGA 
Secondary metabolites refer to those compounds that are not used 
by the organisms for their primary metabolisms. Secondary 
metabolites influence other organisms in the vicinity and are 
thought to be of phylogenetic importance (Carpine & Sieber, 
2021). Secondary metabolites include several types of compounds 
that may act as hormones, antibiotics, allelochemicals, toxins, and 
biotoxins that are found in surface supplies of fresh water 
(Carmichael, 1992). The ability of such compounds to kill bacteria 
and fungi have been well documented (Bonjouklian et al., 1988). 
The properties of secondary metabolites in nature are not 
completely understood (Metting & Pyne, 1986; Inderjit & 
Dakshini, 1994; Vasudevan et al., 2020).  
The blue-green algae bear the characteristics to secrete vitamins, 
amino acids, fatty acids, carbohydrates, and various primary and 
secondary metabolites like amines, histamines, histidine, tannins, 
terpenoids, bromophenol, and polysaccharides (Figure 11). Few 
of these compounds are proven to be biologically active (Metting 
& Pyne, 1986; Padmini et al., 2021). The recent examples are 
cyanovirin-N secreted by Nostoc ellipososoporum and anti-HIV 
glycolipids secreted by Isochyrosis and bromophenol are 
secreted by Calothrix sp. (Jaspars & Lawton 1998; Safari et al., 
2020). 
 
Figure 9 Pharmaceutical Potential of Blue-Green Algae 
 
Figure 10 Major Phytochemicals constituents 



















2.1.1 Antibacterial Potential of BGA 
BGA are known for the secretions of antibacterial compounds with 
potential antibacterial activity against both Gram-positive and Gram-
negative bacteria. Several strains such as Anabaena, Lyngbya, 
Calothrix, Spirulina, Nostoc, Hapalosiphone, Phormidium, and 
Oscillatoria have been identified by researchers from different 
habitats which can produce a wide variety of antibacterial molecules 
having therapeutic potentials (Chauhan et al., 2022). These 
organisms are even being altered genetically using biotechnological 
interventions for the production of various active compounds having 
antibacterial activity such as Bacteriocin Ambigol A, Parsiguine, 
Hapalindole, Hormothamnin A. Bacillus subtilis, Staphylococcus 
aureus, Streptococcus sanguinis, Pseudomonas aeruginosa, 
Escherichia coli, L. monocytogenes, Salmonella typhimurium, 
Enterobacter aerogenes, Klebsiella pneumonia, Methicillin-resistant 
B. anthracis are the examples of some gram-positive and Gram-
negative bacteria which have studied for the inhibitory action of 
BGA (Luesch et al., 2001; Muller et al., 2006; Mo et al., 2009; 
Sturdy et al., 2010). The first partly identified antimicrobial 
compound isolated from algae were obtained from unicellular green 
algae particularly, Chlorella which contained a substance termed as 
‘chlorellin’ that exhibited inhibitory activity against both Gram-
positive and Gram-negative bacteria, including Staphylococcus 
aureus, Streptococcus pyogenes, Bacillus subtilis, and Pseudomonas 
aeruginosa (Pratt et al., 1944). Chlorellin is composed of peroxides 
of unsaturated fatty acids (Spoehr & Milner, 1949). Kaushik & 
Chauhan (2008a) had reported the antibacterial activity of several 
species of cyanobacteria such as Anabaena, Lyngbya, Calothrix, 
Spirulina, Nostoc, Hapalosiphone, Phormidium, and Oscillatoria, 
etc. against both Gram-positive (Staphylococcus aureus, Bacillus 
subtilis, Bacillus cereus, etc.) and Gram-negative bacteria 
(Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, 
etc.). In a similar study, various species of Anabaena were 
evaluated for their antimicrobial activity and active antibacterial 
extracts were further screened for the presence of various chemical 
constituents through HPTLC techniques (Kaushik et al., 2009; 
Chauhan et al., 2010). Extracts of Nostoc commune and Lyngbya 
majuscula were studied for potent antimicrobial activity against 
clinically significant microorganisms (Kaushik & Chauhan, 2008a; 
Kaushik & Chauhan 2008b; Kaushik et al., 2009; Verma et al., 
2016). HPTLC analysis were also performed to identify novel 
pharmaceutical compounds responsible for the activity. In a recent 
study, El-Sheekh et al. (2021) have evaluated the antibacterial 
activity of Oscillatoria sp. and Spirulina mediated silver and gold 
nanoparticles. Two new antibacterial molecules namely 
Arachidonoyl dopamine and fluocinolone recently discovered from 
methanolic extracts of Arthrospira platensis, a BGA isolated from 
a hypersaline lake in Rajasthan, India (Singh et al., 2021b). In 
another study, Antibacterial efficacy extracts of Oxynema 
thaianum have been assessed against multi-drug-resistant bacteria 
such as E. coli and K. pneumoniae (Padmini et al., 2021). 
Antibacterial compounds discovered from various species of BGA 
have been listed in Table 1 and Figure 12. 
 
Figure 11 Pharmaceutically Important Compounds isolated from BGA 
 
 



































































IUPAC Name: 3-methylbut-2-enyl 5-methyl-2-[5-methyl-2-[1-[3-methyl-
2-(2-methylbut-3-en-2-ylamino)butanoyl]pyrrolidin-2-yl]-1,3-oxazol-4-
yl]-1,3-oxazole-4-carboxylate 






Compound CID: 10087661 
MF: C18H10Cl2N2 
MW: 325.2g/mol 
IUPAC Name: 3,8-dichloro-11,12-dihydroindolo[2,3-a] carbazole 



































IUPAC Name: 4,5-dihydroxy-1-methylanthracene-9,10-dione 
Jaki et al., 2000 






































Jaki et al., 
















IUPAC Name: 7-methyl-2H-pyrazolo[4,3-e][1,2,4]triazin-3-one 








IUPAC Name: (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid 













MacMillan &  
Molinski, 2005; 
Matern et al., 2001 




























































IUPAC Name: 6-chloro-2-methyl-9H-pyrido[3,4-b]indol-2-ium;iodide 


















































Choi et al., 2010 
Nostoc sp. 
MGL001 
9-Ethyliminomethyl-12-(morpholin-4- ylmethoxy) 5, 8, 13, 16-tetraaza-hexacene-2, 3  
dicarboxy-licacid (EMTAHDCA) 




    




Muscoride A Tjipanazole D Kawaguchipeptin A Tenuecyclamide A 
    
1,8-dihydroxy-4-methyl 
anthraquinone 
Calothrixin A Comnastin A Nostocyclyne A 
    


















2.1.2 Antimycobacterial potential of BGA  
BGA extracts and compounds have been tested against various 
species of Mycobacteria. Rao et al. (2007) reported the 
antimycobacterial activity of different spp. of BGA viz., 
Hapalosiphon sp., Anabaena sp. Lyngbya sp., Westeillopsis 
prolifica, Spirulina sp. Anabaena variabiles, Anabaena cylindrica, 
Oscillatoria sp. andScytonema sp. against Mycobacterium 
tuberculosis ATCC 27294, M. tuberculosis MDR, M.avium, M. 
intracellulare, and M. aurum. Other BGA species which exhibit 
antimycobacterial potential are Tychonema sp., Fischerella 
ambigua are Lyngbyama juscule (Muller et al., 2006; Mo et al., 
2009; Sturdy et al., 2010; Luesch et al., 2001). Antimycobacterial 
compounds produced by these BGA strains are summarized in 
Table 2. 
2.1.3 Antifungal potential of BGA 
Antifungal properties of BGA strains have been documented 
globally. Fungal and yeast strains such as Candida friedricki, 
Fusarium oxysporum, Aspergillus fumigatus, Alternaria alternate, 
A. niger, C. albicans, A. parasiticus, A. flavus, A. westerdijikia, A. 
ochraceus ITAL 14, A. carbonarius ITAL 204, A. steynii IBT 
LKN 23096, Penicillium verrucosum BFE 500, F. verticillioides 
ITEM 10027, F. proliferatum MPVP 328 have been tested with 
BGA extracts and compounds (Marrez & Sultan, 2016; Vanlalveni 
et al., 2018; Saurav et al., 2019). Antifungal compounds reported 
from BGA strains have been listed in Table 3 and Figure 13. 
2.1.4 Antioxidant potential of BGA 
Blue-green algae produce large amounts of antioxidants to protect 
themselves from harmful stress conditions so that the cells can be 
protected from the effect of the reactive oxygen species (ROS) 
produced during stress. Hydrogen peroxide and oxygen free radicals 
are the two harmful reactive oxygen species formed in the cells 
during oxidative stress and can damage the cells (Vasudevan et al., 
2020).  Antioxidant properties of various extracts have been 
evaluated using different assay methods such as DPPH radical-
scavenging Assay, ABTS
+
 (2, 2-azino-bis (3-ethylbenzthiazoline-6-
sulfonic acid); Nitric oxide radical scavenging Assay; Total 
Antioxidant capacity determination kit, and β-carotene bleaching 
assay (Table 5). BGA produces several antioxidants that can 
scavenge these free radicals. These antioxidants have been explored 
as a novel source of dietary supplements because the cyanobacteria 
are rich in phenolics, vitamins, and carotenoids, the most common 
being carotenoids, which can be used for alleviating oxidative stress 
and limiting health problems (Nainangu et al., 2020; Gabr et al., 
2020). ROS are also formed in animals and humans during oxidative 
stress and cause damage to the biomolecules such as lipids, proteins, 
and DNA. Oxidative stress is associated with several diseases such 
as cancer, neurodegeneration, retinopathy, aging, and other diseases. 
Algae produce several substances that have antioxidant effects, and 
these substances can be used as dietary supplements by humans 
(Guerreiro et al., 2020; Safari et al., 2020; Li et al., 2020). 
Antioxidant compounds recently purified from Blue-Green Algae are 
summarized in Table 4.  
    
Abietane Hapalindole T Ambigol B  




(morpholin-4- ylmethoxy) 5, 8, 





Ambiguine A isonitrile Crossbyanol A Figure Not available 
 
Figure 12 Chemical structures of the active ingredients isolated from various BGA and having antibacterial potential 
 
 










Table 2 Antimycobacterial compounds reported from BGA 


















































































Table 3 Antifungal compounds reported from BGA 
BGA Spp. Antifungal Compounds Detail of Chemical compounds References 

















Mason et al., 
1982 







































Moore et al., 
1987 

































IUPAC Name: 7,8-dichloro-9-methylpyrido[3,4-b]indole 
Larsen et al., 
1994 































































IUPAC Name: (6R)-6-(hydroxymethyl)-6-undecyloxan-2-one 
 

























































































































































IUPAC Name: 2-(dimethylamino)-N-(5-propyl-1,3,4-thiadiazol-2-yl)acetamide 



























Carazostatin Cyanobacterin Toyocamycin Tubercidin 





















    
Calophycin Bauerine B Cryptophycin 1 Welwitindolinone A isonitrile 
 
   




Tolybyssidin A Tolybyssidin B Lobocyclamine B Nostodione A 
    
Hassallidin A 2,4-dichlorobenzoic acid Swinholide A Tjipanazole B 
   
 
Norharmane AK-3 Hectochlorin Benzoic Acid 
 




















Table 4 Antioxidants compounds recently purified from Blue-Green Algae 
Antioxidants compounds Source References 
Pyrogallol, E-Vanillic, Hespirdin 
 
Spirulina platensis Gabr et al., 2020 
Benzeneacetanomide and Norvaline, n-propargyloxycarbonyl Microcystis aeruginosa 
Vasudevan et al., 
2020 
BHA, Beta tocopherol, Phytosterols Spirulina maxima Gamal et al., 2020 
Caffeic acid, syringic acid, ferulic acid, p-coumaric acid, chlorogenic acid, 
kaempferol, quercetin and apigenin γ-linolenic acid, α-linolenic acid 
Spirulina platensis Bellahcen et al., 2020 
Benzoic acid, 4-(1-azepinyl)azo-, ethyl ester (b) 1,6-methanonaphthalen-1(2H)-ol, 
octahydro-4,8a,9,9-tetramethyl, (c) Dibutyl phthalate, (d) 1,2-benzene dicarboxylic 
acid, (e) Hexadecanoic acid, 2-pentadecyl-1,3-dioxan-5-yl ester 
Oscillatoria sp. SSCM01 Nainangu et al., 2020 
 
 
Table 5 Types of BGA Extracts, Assay methods and their antioxidant potential 










96.33% Gabr et al., 2020 
Microcystis aeruginosa Methanol Extract 
Scavenging ability on 1, 1-diphenyl-
2-picrylhydrazyl radicals (DPPH) 





Vasudevan et al., 
2020 
Spirulina maxima - 
DPPH radical- 
scavenging Assay 
25.73 % Gamal et al., 2020 
Spirulina platensis 
Ethanolic, aqueous, 













DPPH radical scavenging assay 48% 
Nainangu et al., 
2020 
Spirulina platensis crude extracts DPPH radical-scavenging activity 45.75% Safari et al., 2020 
Oscillatoria acuminate Methanolic extract 
DPPH (2, 2- diphenyl-1- 
picrylhydrazyl) 












DPPH radical scavenging assay 
 
Nitric oxide radical scavenging assay 
 
Anti-lipid peroxidation assay 
(467.7 μg/ml) 
 
(IC50 = 28.7 ± 0.1 
μg/ml) 
(IC50 11.9 ± 0.2 
μg/ml) 
Senousy et al., 2020 
Anabaena sp., 
Stigonaema sp. and 
Oscillatoria sp. 
Methanol Extract 
Total Antioxidant capacity 
determination kit 
0.346 (mM/L); 0.36 
(mM/L) and 0.37 
(mM/L) 











DPPH scavenging method, 
 


















2.1.5 Anti-cancer potential of BGA 
BGA extracts and compounds are known to exhibit anticancer 
properties (Shishido et al., 2020; Gara-Ali et al., 2021). Research 
by Jaspers & Lawton (1998) has focused on various biologically 
active compounds from BGA. The curian A, a novel lipid 
compound isolated from Lyngbya majuscula, is a potent inhibitor 
of microtubule assembly with very low IC50 values against L1210 
leukemia cells and CD-46 Burkitt lymphoa cells, at par with those 
for colchicines. Cryptophycin 1 and 8, another anticancer 
compound was first isolated from Nostoc sp. by researchers at 
Merck. The oral supplement of Spirulina fusiformis is known for 
regression of subjects with homogenous leukolakia (Mathew et al., 
1995). The extracts of Spirulina and Dunaliella inhibited the 
chemically induced carcinogenesis in model hamster buccal 
pouches (Schwartz et al., 1988). Studies have also shown that 
sulphated polysachharide, calcium spirulans appears to inhibit 
tumor invasion of melanoma cells and basement membrane 
(Mishima et al., 1998). Aphanizomenon flosaquae extract 
containing a high concentration of phycocyanin inhibited the in 
vitro growth of tumour cells, indicating the sensitivity of cell lines 
to the phycocyanin. A filamentous cyanobacterium Phormidium 
tenue contains several diacylglycerols that inhibit chemically 
induce tumors on mice (Tokuda et al., 1996). Similarly, 
cryprophycin 1 isolated from Nostoc sp. (ATCC 53789) is the most 
potent suppressor of microtubule dynamics i.e. it blocks all cell 
cycles in G2/M phase. Curacin A is isolated from Lyngbya 
majuscule. This compound is found to be a potent inhibitor of 
microtubule assembly. There is a need for immediate attention for 
more novel anticancer drugs so that carcinogenic cells are capable 
of resisting some drugs, like vinca alkaloids and taxanes. These 
drugs failed to treat cancer in a chemotherapeutic way. Cancer is 
known to be the major cause of mortality worldwide. Recently 
some new types of cancer e.g. gliobastoma are increased rapidly. 
Anticancer compounds reported from BGA are summarized in 
Table 6 Figure 14. 



















































Luesch et al., 
2001 










































Cyanobacteria Astaxanthin - 
Chen et al., 
2003 


































et al., 2008 







et al., 2008 
 
   
Calothrixin A Boromycin Scytovirin 
   













2.1.6 Antiviral Potential including SARS-CoV-2  
The globe is so much affected by the dreadful diseases caused 
by infection of viruses such as HIV-acquired immune 
deficiency syndrome. There is also another viral deadly disease 
that is dengue which may have many consequences. Despite 
two former major outbreaks of coronavirus infections i.e. the 
SARS and MERS, the world is still underprepared to 
effectively manage the current COVID-19 pandemic 
outbreak. The researchers were in search of a novel and potent 
drug which will be able to resist those deadly and dreadful viral 
infections throughout the world. Scientists have now invented 
novel, potent, and safe anti-viral agents that are very useful in 
this urgent situation. Recently there is a new scientific 
treatment or therapy which is named highly active 
antiretroviral therapy in short HAART. This is triple therapy 
which is very fruitful and capable in the treatment of HIV 
infections which is very helpful and makes control and 
resistance power in carcinogenic treatment. This therapy can 
create strong viral resistance. But this therapy cannot stop the 
viral agent which is causing such kinds of issues. BGA species 
are also known to produce substances that have been proved to 
be anti-HIV, therefore can be exploited in therapy against 
AIDS (Schaeffer & Krylov, 2000; Carpine & Sieber, 2021) 
 Gustafson et al. (1989) used a tetrazolum-based micro-culture to 
screen extracts of cultured marine cyanobacteria, Lyngbyalager 
heimii, and Phormedium tenue, for the inhibition of HIV-1. This 
led to the discovery of sulfonic acid containing glycolipids as a 
new class of HIV-1- inhibitory compounds. Other cyanobacteria, 
Phormedium cebennse, Oscillatoria raciborskii, Scytonem 
aburmanicum, Calothrix elenkinii, and Anabaena variabilis, gave 
extracts that inhibited HIV-1 and gave positive tests for the 
presence of sulfolipids. 
Compounds and extracts with anti-HIV activity are also active 
against other retroviruses such as Herpes simplex virus (HSV) and 
respiratory syncytial virus, but the amount of antiviral activity 
varies with the compound and the virus. Most of the research has 
focused on sulphated homopolysaccharides and 
heteropolysaccharides, sulfoglycolipids, carrageenans, fucoidan, 
sesquiterpene hydroquinones, and other classes of compounds with 
an anti-HIV activity that has been isolated from algae have 
received less attention. Hayashi et al. (1996) isolated calcium 
spirulan, a sulfated polysaccharide obtained from a marine blue-
green alga, Spirulina platensis which inhibited the Herpes simplex 
virus. Subsequently, Ayehunie et al. (1998) determined that an 
aqueous extract of S. platensis, at a concentration that was non-
toxic to human cells, inhibited syncytium formation and HIV-1 
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replication in human T-cell lines, peripheral blood mononuclear 
cells, and Langerhans cells. The antiviral effects of 
polysaccharides from marine algae towards mumps virus and 
influenza B virus were reported by Gerber et al. (1958). 
Subsequently, polysaccharides fractions from extracts of red algae 
were found to inhibit the herpes simplex virus (HSV). Similarly, 
Boyd et al. (1997) isolated Cyanovirin-N from an aqueous cellular 
extract of cyanobacterium Nostoc ellipsosporum which has been 
proved to be antiviral. Lau et al., (1993) reported that the lipophilic 
and hydrophilic extracts of over 900 strains of cultured blue-green 
algae in vitro for their ability to inhibit the reverse transcriptases of 
avian myeloblastosis virus (Table 7) 
Various compounds have been isolated from a variety of blue-
green algaeBGA-derived polysaccharides that have been reported 
for the inhibition of SARS-CoV-2 (Sami et al., 2021). Few 
organizations are actively involved in developing algae-based 
edible vaccines for SARS-CoV-2 (Jafari et al., 2021) (Table 8) 
2.1.7 Antidiabetic Potential of BGA 
Blue-green algae are known to exhibit potential antidiabetic 
properties. In a study conducted by Priatni et al. (2016) 
methanol extract of marine cyanobacterial strains such as 
Oscillatoria limnetica, Coelastrella sp., Oscillatoria sp., 
Chroococcus sp., Leptolyngbya sp., Pseudanabaena sp.,  
Lyngbya sp., Aphanothece sp., Phormidiumsp, and 
Synechococcus sp. have potential antidiabetic potential. The 
metabolites of Pseudanabaena sp. showed the highest α-
glucosidase inhibition. In another study, Egyptian Scientists 
evaluated extracts of Fischerella sp. BS1-EG for antidiabetic 
Table 7 Antiviral Compounds reported from BGA 
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potential and have reported certain bioactive compounds 
responsible for the activity (Ahmed et al., 2018). In a recent 
study, Sridhar et al. (2021) have evaluated phycocyanin of S. 
platensis for its antidiabetic potential by assessing α-amylase 
and β-glucosidase enzyme inhibition using spectroscopy 
techniques. In this in vitro test, significant Antidiabetic activity 
(88%) was observed at a concentration of 250 μg/ml. In some 
studies, lesser antidiabetic properties have been reported, like 
Ghosh et al. (2016) evaluated in vitro antidiabetic properties of 
molecules from Lyngbya, Microcoleus, and Synechocystis sp. 
by α-amylase inhibition method and stated the lesser enzyme 
inhibition effect. Similarly, Xu et al. (2012) described the 
lowest α-amylase enzyme inhibition activity of Phlorotannins 
pigments extracted from Eckloniakurome. However, Hwang et 
al. (2014) reported 65 - 80% inhibitory activity at the 
concentration of 250 μg/ml while this was reported 51 - 67% at 
the dose of 200 μg/ml dose of S. platensis phycocyanin. Lesser 
enzyme inhibition even in higher concentrations was reported 
in a study conducted by Priatni et al. (2016). 
2.1.8 Anti-inflammatory Activity of BGA 
Blue-Green Algae contain a significant amount of carotenoids i.e. 
β-carotene, lycopene, lutein having antioxidant properties. By the 
quenching action on the reactive oxygen species, these carotenoids 
also have anti-inflammatory activity. This anti-inflammatory 
activity might be due to the presence of phycocyanin, a photo 
harvesting pigment. Further, the anti-inflammatory effect seemed 
to be the result of leucotriene formation inhibition by phycocyanin, 
an inflammatory metabolite of arachidonic acid (Romay et al., 
1999). Apbanizomenon flosaquae decrease the level of arachidonic 
acid. Further, A. flosaquae and Spirulina contain significant 
amount of omega-3-alpha linolenic acid which inhibits the 
formation of inflammatory prostaglandins and arachidonate 
metabolites (Figure 15). 
3 Conclusion and Future possibilities  
BGA are groups of extraordinary, diverse, gram-negative, 
oxygenic, photosynthetic prokaryotic microscopic organisms. 
Table 8 Anti-HIV activity of compounds from BGA 
BGA strains Compounds References 
Anabaena variabilis, Calothrix elenkinii, Lyngbya 
lagerheimii, Phormidium tenue, Phormedium  
cebennse, Oscillatoria raciborskii, Scytonema  
burmanicum 
Extracts containing sulfolipids (sulfoquinovosyl 
diacylglycerols) 
Gustafson et al., 1989 
Spirulina platensis activity in polysaccharide fraction Ayehunie et al., 1998 
Spirulina platensis (Marine) 
Calcium spirulan, Ca-SP 
(sulfated polysaccharide fraction) Dextran sulfate 
Hayashi et al., 1996 
Nostoc ellipsosporum Cyanovirin- N (11-k Da antiviral protein Gustafson et al., 1996 
Nostoc ellipsosporum Cyanovirin- N (11-k Da antiviral protein Boyd et al., 1996 
900 strains Lipophilic and Hydrophilic extracts Lau et al., 1993 
Scytonema spp. Sulfoglycolipids Reshef et al., 1997 
Oscillatoria spp. Acylated diglycolipids Reshef et al., 1997 
Oscillatoria raoi(TAU IL-76-12), Syctonema spp. 
(TAU SL-30-1-4), Oscillatoria trichoides(TAU 
IL 104-3-2), Phormidium tenue ( TAU IL-144-1), 
Oscillatoria limnetica,  Lammermann (TAU NG-
4-1-2) 
Sulfolipids, Sulfoglycolipids, hydrolysis products, 
synthetic derivative 
Loya et al., 1998 
 
 


















Blue-green algae are found all over the world, showing remarkable 
ecological diversity of habitats such as freshwater, terrestrial, 
marine, hot spring, etc. These BGA are also widely distributed in 
the polar region such as the Arctic, Antarctic, Southern Ocean, and 
the Himalayas. Several studies have been conducted for the 
isolation and identification of Blue-Green algae from the water, 
soil, sediments, algal mats, etc. using advanced morphological, 
physiological, and molecular characterization techniques. Various 
selective media are known for their Cultivation. It has been now 
proven that BGA offers a great opportunity as these are considered 
to be one of the potential organisms useful to mankind in many 
ways. They exhibit diverse biological activities (Antibacterial, 
Antifungal, Anticancer, Antiviral Antidiabetic, and many more). 
Various bioactive molecules have been reported by researchers 
globally. In pharmaceutical companies especially in the new drug 
discovery research division, for the last many year's research is 
going on at various levels starting from extraction, purification, 
and identification of new compounds or drugs from various species 
of BGA. The major challenge in front of the current world is to 
fight effectively against the new emerging diseases and microbes 
specifically WHO priorities list of multiple antibiotic-resistant 
bacteria, microbial infections including SARS-CoV-2 virus and 
Cancer, etc., and to discover new pharmaceutical compounds for 
mankind and society. At the same time, there is an urgent need to 
think from basic to applied research to commercialize several 
value-added products. The use of nanomaterials to enhance 
biological activity could be one of the ways. Inventions of these 
drugs using nanotechnology can lead to the development of novel 
pharmaceuticals. Based on the cultures of cells, activities of 
enzymes, and receptors binding with ligands, various new 
technologies are invented to develop novel things of miniaturized 
screens. As a result, there is a conformational analysis, i.e., an 
analysis of the spatial arrangement of the component atom within a 
molecule that can be rotated about one or more single bonds. The 
known ligands result in the development of new compounds of 
structure-based drug design. Hence, the pharmaceutical potential 
of blue-green algae deserves more scientific attention and 
interdisciplinary research, and BGA strains from still unexplored 
and extreme habitats such as the Antarctic, Arctic, and the 
Himalayas can serve as good candidates in this regard. 
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